Cartalax Peptide Bioregulator Description
Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.
Peptide Information
| Value |
|---|
| Ala-Glu-Asp |
| C12H19N3O8 |
| 333.29 g/mol |
| 87815447 |
| Ala-Glu-Asp, alanyl-glutamyl-aspartic acid, T-31 peptide, H-Ala-Glu-Asp-OH |
Cartalax Structure
Source: PubChem
